The in vitro susceptibilities of 16 Mycobacterium marinum strains to eight antimicrobial agents were determined by the agar dilution technique. The most active drugs were amikacin and kanamycin. Tetracycline, doxycycline, and minocycline were inhibitory, predominantly at concentrations slightly below the expected blood and tissue levels. Trimethoprim-sulfamethoxazole and erythromycin demonstrated activity only at concentrations greater than those usually attained in serum and tissues. Gentamicin was relatively inactive.
MATERIALS AND METHODS
Sixteen strains of M. marinum were obtained from the mycobacteriology laboratory of Cleveland Metropolitan General Hospital. These strains included 11 recent isolates from human soft-tissue infections (three were provided by William Hanke of the Cleveland Clinic) and five laboratory strains from the Mycobacterial Culture Collection formerly at the Trudeau Institute, Saranac Lake, N. Y., or from Werner Schaefer (one strain was the original Aronson fish strain [1] ).
Susceptibilities were determined by the agar dilution method, using serial twofold dilutions of drugs in Mueller-Hinton agar (BBL Microbiology Systems, Cockeysville, Md.) contained in quadrant plates. In a preliminary experiment with three strains using the disk diffusion method, most of the drugs showed greater activity in Mueller-Hinton agar than in Middlebrook 7H10 agar (Difco Laboratories, Detroit, Mich.). Drug concentrations ranged from 0.3 to 10 ,ug of amikacin, gentamicin, and kanamycin per ml; 0.6 to 20 ag of doxycycline, minocycline, and TMP-S per ml; 3.1 to 100 ,g of tetracycline per ml; and 1 
RESULTS
The miniimal inhibitory concentrations are depicted in Fig. 1 . Amikacin and kanamycin produced the greatest inhibition with 89 and 62% of strains, respectively, inhibited at 2.5 ,ug/ml, and 100 and 94%, respectively, inhibited at 5,g/ml. Gentamicin, however, inhibited only 44% of strains at 10 ,ug/ml, the highest concentration tested.
Tetracycline, doxycycline, and minocycline all showed similar activity, (miniimal inhibitory concentrations ranging from 2.5 to 20 ,ug/ml) requiring approximately 4 to 7 jig/ml to inhibit 50% of the strains. TMP-S also showed activity in this range, but the endpoint was sometimes difficult to determine because of persistent growth of tiny colonies. Erythromycin was slightly less inhibitory than the tetracyclines and TMP-S. Although tetracyclines were clinically effective (5, 9, (12) (13) (14) , two studies noted in vitro resistance of M. marinum to tetracycline at 100 jig/ml (12) and 25 to 50,ug/ml (9) . Because these concentrations greatly exceeded the usual achievable blood levels (3 to 6 ,ug/ml), the therapeutic effect was considered by one author to be on a basis other than antibacterial activity (16) . In the present investigation, it was found that the three tetracyclines inhibited 50% of the strains at levels that might be obtained in the tissues. These results are similar to those of a previous study in which 32 strains were tested against minocycline and doxycyline using the agar dilution technique and Middlebrook 7H11 agar (18) .
DISCUSSION
TMP-S was effective clinically in several studies (3, 4, 11, 19) , and M. marinum strains have been reported to be "susceptible in vitro" without details of methodology (3, 4, 7, 8) . In the present study, TMP-S inhibited 100, 88, and 31% ANTIMICROB. AGENTS CHEMOTHER.
of strains at 20, 10, and 5 jig of trimethoprim per ml, respectively. Since serum trimethoprim levels after the usual doses of TMP-S are generally 3 ,tg/ml (10) , the relationship between these in vitro data and reported clinical effectiveness is uncertain.
Erythromycin alone or in combination with other agents yielded equivocal results in the treatment of M. marinum infections (6, 20) . In the present study, the minimal inhibitory concentrations were found to be several times higher than the usual achievable concentrations in serum.
As far as we could determine, the 16 cultures reported in this study represented 16 different strains. Five others sent as proficiency test samples by the College of American Pathologists and the Center for Disease Control were duplicates of two stock strains, and these were included in the data used to construct Fig. 1 . Omitting these five strains did not change the curves appreciably.
